Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeted protein degradation: advances in drug discovery and clinical practice
Guangcai Zhong, Xiaoyu Chang, Weilin Xie, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 13

Showing 13 citing articles:

Identifying Semaphorin 3C as a Biomarker for Sarcopenia and Coronary Artery Disease Via Bioinformatics and Machine Learning
Ran Shu, Zhuoqi Li, Xitong Lin, et al.
Archives of Gerontology and Geriatrics (2025) Vol. 131, pp. 105762-105762
Closed Access
PROTACs coupled with oligonucleotides to tackle the undruggable
Guangshuai Zhang, Si Yan, Yan Liu, et al.
Bioanalysis (2025), pp. 1-16
Closed Access
Identification of actionable targeted protein degradation effector sites through Site-specific Ligand Incorporation-induced Proximity (SLIP)
Zhangping Xiao, Efthymios Spyridon Gavriil, Fangyuan Cao, et al.
(2025)
Open Access
Design, Synthesis, and Biological Evaluation of Novel BTK-targeting Proteolysis Targeting Chimeras (PROTACs) with Enhanced Pharmacokinetic Properties
Ying‐Hung Lin, Jing Liu, Xiaohe Tian, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117420-117420
Closed Access
PSPC1 bridges cancer stemness and malignancy in acute myeloid leukemia
Hsi-Wen Yeh, Yaw‐Dong Lang, Hsin‐Yi Lee, et al.
Cell stem cell (2025) Vol. 32, Iss. 3, pp. 335-337
Closed Access
The Endo-GeneScreen Platform Identifies Drug-Like Probes that Regulate Endogenous Protein Levels within Physiological Contexts
Preston Samowitz, László Radnai, Thomas Vaissière, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Closed Access
Design and Synthesis of a Clickable Cell-Permeable Pseudopeptide Pin1 Inhibitor with Antiproliferative Effects on Human Multiple Myeloma Cell Line
Lorenzo Meneghelli, Stephanie Davidson, Anthony Gineste, et al.
Chemical Communications (2025)
Closed Access
Potential Benefits of In Silico Methods: A Promising Alternative in Natural Compound’s Drug Discovery and Repurposing for HBV Therapy
Samuel Chima Ugbaja, Aganze Gloire-Aimé Mushebenge, Hezekiel M. Kumalo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 419-419
Open Access
E3 ubiquitin ligases and their therapeutic potential in disease Management
Geet Madhukar, Md Azizul Haque, Shawez Khan, et al.
Biochemical Pharmacology (2025), pp. 116875-116875
Closed Access
Deubiquitinase-Targeting Chimeras (DUBTACs) as a Potential Paradigm-Shifting Drug Discovery Approach
Zonghui Ma, Mingxiang Zhou, Haiying Chen, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Discovery of the First-in-class DOT1L PROTAC Degrader
Hyerin Yim, Renhong Sun, Zhongli Xu, et al.
European Journal of Medicinal Chemistry (2025), pp. 117595-117595
Closed Access
Advancing target validation with PROTAC technology
Margaret Spitz, Aseel Kashkush, Raphael I. Benhamou
Expert Opinion on Drug Discovery (2025)
Closed Access
Harnessing the SPOP E3 Ubiquitin Ligase via a Bridged Proteolysis Targeting Chimera (PROTAC) Strategy for Targeted Protein Degradation
Zhijie Deng, Jerrel L. Catlett, Youngeun Lee, et al.
Journal of Medicinal Chemistry (2025)
Closed Access
Immunoconjugates as an Efficient Platform for Drug Delivery: A Resurgence of Natural Products in Targeted Antitumor Therapy
Rositsa Mihaylova, Denitsa Momekova, Viktoria Elincheva, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 12, pp. 1701-1701
Open Access
Page 1

Scroll to top